PRDM9 and cancer: In addition, inhibitors targeting the histone methyltransferase DOT1L and the demethylase LSD1 are being explored for their therapeutic potential, as they can modify the epigenetic landscape of cancer cells and influence gene expression without disrupting the DNA sequence.53